Deciding two connected writ petitions arising from a common Industrial Tribunal Award, the Delhi High Court set aside the Tribunal's direction granting hotel workmen a further…
Labour Laws
06/09/20264 min read
← back
Informative
PharmEasy-Owned Thyrocare’s Q2 Profit Zooms 81% YoY To INR 48 Cr
Appeal Against OrderExcise, VAT & Custom
Thyrocare, owned by PharmEasy, reported an 81% year-on-year increase in Q2 profits to ₹48 crore, driven by strong diagnostic demand and cost optimization measures. The growth highlights the consolidation trend in India’s healthtech sector and the operational synergies achieved post-acquisition. Analysts note that Thyrocare’s robust performance reflects its market leadership in diagnostics, strategic pricing, and expansion into new geographies, showcasing the financial viability of healthcare-focused startups.
